Steris Healthcare Private Limited

Gliclazide (80mg),Also Available on PCD Pharma Franchise. Gliclazide (80mg) marketed as GLICLAGLAZE 80, is a widely used oral medication for managing type 2 diabetes mellitus. This drug belongs to the sulfonylurea class, which helps control blood sugar levels by stimulating insulin production in the pancreas. It's particularly beneficial for patients who cannot manage their diabetes through diet and exercise alone.

• Stimulates Insulin Secretion: Gliclazide works by stimulating the beta cells in the pancreas to release more insulin.
• Improves Insulin Sensitivity: It also enhances the body's sensitivity to insulin, allowing for more efficient glucose uptake by cells.
• Reduces Glucose Production: The medication decreases glucose production in the liver, contributing to lower blood sugar levels.

• Type 2 Diabetes Management: Primarily used to control blood sugar levels in individuals with type 2 diabetes.
• Prevent Complications: Helps in preventing complications such as nerve damage, kidney damage, and heart issues associated with high blood sugar levels.

GLICLAGLAZE 80 PCD Pharma is a brand of Gliclazide (80mg) designed to provide effective management of type 2 diabetes. It comes in tablet form and is taken orally, usually once or twice daily as prescribed by a healthcare provider.

• Common Side Effects: Nausea, dizziness, and headache.
• Hypoglycemia: Risk of low blood sugar, characterized by symptoms such as sweating, shaking, and confusion.
• Weight Gain: Some patients may experience a slight increase in weight.
• Allergic Reactions: Rarely, it can cause allergic reactions like skin rash, itching, or swelling.

• Regular Monitoring: Regular blood sugar monitoring is essential to avoid hypoglycemia.
• Diet and Exercise: Adhere to prescribed diet and exercise regimens for optimal results.
• Avoid Alcohol: Alcohol can increase the risk of hypoglycemia and should be avoided.
• Medication Interactions: Inform your doctor about any other medications you are taking to prevent adverse interactions.

Dapagliflozin and metformin Sustained Release Tablets combination is used together with proper diet and exercise to treat type 2 diabetes. It is also used to lower the risk of hospitalization for heart failure in patients with type 2 diabetes and cardiovascular (heart or blood vessel) disease or multiple cardiovascular risk factors.

VOGLIGOLD M 0.3 is Also Available on PCD Pharma Franchise.VOGLIGOLD M 0.3 a combination medication used to manage blood sugar levels in patients with type 2 diabetes. It combines Voglibose 0.2 mg and Metformin SR 500 mg, two effective antidiabetic agents that work together to improve glycemic control. This combination is particularly beneficial for patients who require additional medication to achieve optimal blood sugar levels.

• Voglibose: An alpha-glucosidase inhibitor that delays the absorption of carbohydrates in the intestine, leading to a slower rise in blood glucose levels post meals.
• Metformin SR: A biguanide that reduces hepatic glucose production and increases insulin sensitivity, improving glucose uptake and utilization by the muscles.

• Type 2 Diabetes Management: Helps in controlling blood sugar levels in adults with type 2 diabetes.
• Preventing Complications: Reduces the risk of diabetes-related complications such as cardiovascular diseases, neuropathy, and retinopathy.

VOGLIGOLD M 0.3 is a combination of two medications, Voglibose and Metformin SR, used primarily to manage and control high blood sugar levels in patients with type 2 diabetes. This combination is often prescribed when diet, exercise, and other medications do not provide adequate glycemic control.

• Gastrointestinal issues such as nausea, vomiting, and diarrhea.
• Abdominal pain and bloating.
• Hypoglycemia (low blood sugar levels).
• Lactic acidosis (rare but serious condition).

• Consult Your Doctor: Before starting VOGLIGOLD M 0.3 PCD Pharma inform your doctor about any other medications you are taking and your complete medical history.
• Monitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to adjust the dosage as needed.
• Diet and Exercise: Maintain a healthy diet and regular exercise routine to enhance the medication's effectiveness.
• Avoid Alcohol: Limit alcohol intake, as it can increase the risk of lactic acidosis and hypoglycemia.

GLIDAPA TENE 10/20 Also Available on PCD Pharma Franchise. GLIDAPA TENE 10/20 combines two potent medications, Dapagliflozin and Teneligliptin, designed to manage Type 2 Diabetes Mellitus effectively. This combination works by targeting different mechanisms in the body to control blood sugar levels, providing a comprehensive approach to diabetes management.

How Does PCD Pharma Products GLIDAPA TENE 10/20 Work?

• Dapagliflozin: A sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps the kidneys remove glucose from the bloodstream through urine.
• Teneligliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that increases insulin release and decreases the amount of glucose produced by the liver.

Uses

• Helps improve glycemic control in adults with Type 2 Diabetes.
• Reduces the risk of cardiovascular events in diabetic patients.
• Can be used as monotherapy or in combination with other antidiabetic agents.

What is GLIDAPA TENE 10/20?

GLIDAPA TENE 10/20 PCD Pharma is an oral antidiabetic medication that combines 10mg of Dapagliflozin and 20mg of Teneligliptin, providing dual action in lowering blood glucose levels.

Side Effects

• Common: Urinary tract infections, genital infections, increased urination.
• Less common: Hypoglycemia (low blood sugar), dizziness, dehydration.

Safety Information

• Not recommended for patients with severe kidney impairment.
• Monitor for signs of dehydration and maintain adequate fluid intake.
• Regular blood sugar monitoring is essential to avoid hypoglycemia.
• Consult with a healthcare provider before starting or adjusting dosage.

Teneligliptin 20mg and Dapagliflozin Propanediol Monohydrate 5mg Also Available on PCD Pharma Franchise.

 marketed under the name GLIDAPA TENE 5/20, is a combination medication used to manage type 2 diabetes. This medication leverages the complementary mechanisms of Teneligliptin, a DPP-4 inhibitor, and Dapagliflozin, an SGLT2 inhibitor, to effectively control blood glucose levels.

• Inhibits DPP-4 enzyme
• Increases incretin hormone levels
• Enhances insulin secretion
• Reduces glucagon levels

• Inhibits SGLT2 in kidneys
• Reduces glucose reabsorption
• Increases glucose excretion via urine
• Lowers blood glucose levels

• Manages type 2 diabetes
• Improves glycemic control
• Reduces the risk of cardiovascular events

• Hypoglycemia
• Urinary tract infections
• Nasopharyngitis
• Diarrhea
• Headache

• Monitor renal function
• Avoid in severe renal impairment
• Caution in elderly patients
• Stay hydrated to prevent dehydration
• Consult a doctor before use during pregnancy or lactation

Pioglitazone (30mg), marketed as PIOSTERIS 30 Also Available on PCD Pharma Franchise, PIOSTERIS 30 is a prescription medication primarily used to manage type 2 diabetes. By enhancing insulin sensitivity, it helps in maintaining blood glucose levels within the desired range, thus playing a critical role in diabetes management.

How Does PCD Pharma Products PIOSTERIS 30 Work

• Insulin Sensitizer: Pioglitazone belongs to a class of drugs known as thiazolidinediones. It works by increasing the body's sensitivity to insulin.
• Glucose Regulation: It helps in reducing the amount of glucose produced by the liver and increases the uptake of glucose by the cells, particularly muscle cells.
• Adipose Tissue Effect: It promotes the storage of fatty acids in adipose tissue, preventing the circulation of excess fatty acids that can contribute to insulin resistance.

Uses of Pioglitazone (30mg)

• Type 2 Diabetes Management: Used as a monotherapy or in combination with other medications like metformin or sulfonylureas to control blood sugar levels.
• Insulin Resistance Reduction: Helps in reducing insulin resistance, particularly in overweight individuals.
• Preventing Complications: Aids in preventing diabetes-related complications such as nerve damage, kidney issues, and eye problems.

What is Pioglitazone (30mg)

Pioglitazone (30mg) PCD Pharma is an oral antidiabetic medication designed to improve blood sugar control in adults with type 2 diabetes. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.

Side Effects

• Common Side Effects: May include weight gain, fluid retention, and upper respiratory tract infections.
• Serious Side Effects: Can include heart failure, liver problems, and an increased risk of fractures. Monitoring for symptoms like shortness of breath, swelling, or jaundice is crucial.
• Allergic Reactions: Symptoms such as rash, itching, or swelling, especially of the face, tongue, or throat, require immediate medical attention.

Safety Information

• Medical History: Inform your doctor about any history of heart disease, liver problems, or bladder cancer.
• Regular Monitoring: Regular blood tests are necessary to monitor liver function and blood sugar levels.
• Medication Interactions: Be cautious about potential interactions with other medications, including over-the-counter drugs and supplements.
• Pregnancy and Breastfeeding: Pioglitazone is not recommended during pregnancy or breastfeeding unless deemed absolutely necessary by a healthcare provider.

TRIGLICLAGLAZE 30 combines three potent antidiabetic agents: Gliclazide (SR), Pioglitazone, and Metformin HCL (SR). This medication is designed to provide comprehensive glycemic control for patients with type 2 diabetes. By targeting different mechanisms of action, it helps in managing blood sugar levels effectively.

• Gliclazide (SR): Stimulates the pancreas to release more insulin, helping to lower blood sugar levels.
• Pioglitazone: Improves insulin sensitivity by making body cells more responsive to insulin.
• Metformin HCL (SR): Reduces glucose production in the liver and improves insulin sensitivity in the muscles.

• Management of type 2 diabetes mellitus in adults.
• Helps in achieving better glycemic control when diet and exercise alone are insufficient.
• Used as part of a comprehensive diabetes management plan.

TRIGLICLAGLAZE 30 is a fixed-dose combination medication that contains Gliclazide (SR), Pioglitazone, and Metformin HCL (SR). This combination targets multiple pathways to regulate blood sugar levels, making it a valuable treatment option for patients struggling with type 2 diabetes.

• Common: Nausea, diarrhea, abdominal pain, and hypoglycemia.
• Less common: Weight gain, edema, and headache.
• Serious: Lactic acidosis (a rare but serious side effect of Metformin), liver dysfunction, and heart failure.

• Regularly monitor blood sugar levels and report any significant changes to your healthcare provider.
• Inform your doctor about any other medications or supplements you are taking to avoid potential interactions.
• Follow a balanced diet and exercise regimen as recommended by your healthcare provider.
• Do not consume alcohol excessively, as it can increase the risk of lactic acidosis and hypoglycemia.
• Notify your healthcare provider if you experience any signs of heart failure, such as shortness of breath, swelling in the legs, or sudden weight gain.

TRIGLICLAGLAZE 60 Also Available on PCD Pharma Franchise. TRIGLICLAGLAZE 60 is a powerful combination medication containing Gliclazide 60mg (SR), Pioglitazone 15mg, and Metformin HCL 500mg (SR). It is specifically designed to provide comprehensive management of type 2 diabetes by targeting multiple pathways of glucose regulation.

How Does PCD Pharma Products TRIGLICLAGLAZE 60 Work?

• Gliclazide (SR): Stimulates the pancreas to release more insulin, reducing blood sugar levels.
• Pioglitazone: Enhances the body’s sensitivity to insulin, allowing for better glucose utilization.
• Metformin (SR): Reduces glucose production in the liver and improves insulin sensitivity in muscles.

Uses of TRIGLICLAGLAZE 60

• Blood Sugar Regulation: Helps maintain stable blood glucose levels throughout the day.
• Enhanced Glycemic Control: Combines the benefits of three different medications to optimize blood sugar management.
• Prevention of Complications: Lowers the risk of diabetes-related complications such as cardiovascular diseases, neuropathy, and retinopathy.

What is TRIGLICLAGLAZE 60?

PCD Pharma TRIGLICLAGLAZE 60 is a combination drug used in the treatment of type 2 diabetes mellitus. It integrates the effects of Gliclazide, Pioglitazone, and Metformin to provide a comprehensive approach to blood sugar control.

Side Effects

• Common: Hypoglycemia, gastrointestinal disturbances, weight gain, edema.
• Serious: Lactic acidosis (rare), heart failure, liver dysfunction.
• Allergic Reactions: Rash, itching, swelling, severe dizziness.

Safety Information

• Consult Your Doctor: Prior to using TRIGLICLAGLAZE 60, especially if you have liver, kidney, or heart conditions.
• Regular Monitoring: Frequent blood sugar and liver function tests are advised to ensure safety and effectiveness.
• Diet and Exercise: Maintain a healthy diet and regular physical activity to support medication efficacy.
• Avoid Alcohol: Alcohol can increase the risk of hypoglycemia and lactic acidosis.
• Inform About Other Medications: Disclose any other medications or supplements you are taking to avoid potential interactions.

ST GLIPTIN 25 is a pharmaceutical product containing Sitagliptin, an effective medication used to control blood sugar levels in individuals with Type 2 diabetes mellitus. It belongs to a class of drugs known as DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors). This medication is often prescribed in combination with other antidiabetic drugs or diet and exercise plans to help manage blood sugar levels and reduce the risk of complications associated with diabetes, such as heart disease, nerve damage, and kidney problems.

• Sitagliptin Tablet IP 25 mg: The active ingredient Sitagliptin works by increasing the levels of incretin hormones, which help regulate insulin production in response to meals. It also lowers the amount of glucose produced by the liver.

• Effective Blood Sugar Control: ST GLIPTIN 25 helps to manage blood sugar levels in adults with Type 2 diabetes, especially when used alongside proper diet and exercise.
• Minimal Risk of Hypoglycemia: Unlike some other diabetes medications, Sitagliptin generally does not cause hypoglycemia (low blood sugar) when used alone.
• Promotes Healthy Insulin Levels: Sitagliptin helps enhance the body’s natural release of insulin after meals, improving overall glucose management.
• Supports Heart Health: Maintaining stable blood sugar levels can reduce the risk of cardiovascular complications, making it an important part of a diabetes management plan.

ST GLIPTIN 25 (Sitagliptin) works by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones. These hormones play a key role in regulating blood glucose levels by stimulating insulin release and decreasing glucose production in the liver. By inhibiting DPP-4, Sitagliptin increases the levels of active incretin hormones, leading to better control over blood sugar levels, especially after meals.

• Dosage: The recommended dose is typically 25 mg taken once daily, as directed by your healthcare provider. This dosage may be adjusted based on the individual's health condition and response to treatment.
• Method: ST GLIPTIN 25 can be taken with or without food. Swallow the tablet whole with a glass of water. To achieve the best results, it's important to take the medication at the same time each day.
• Consistency: It's essential to continue taking ST GLIPTIN 25 as prescribed, even if you feel well. Do not stop the medication without consulting your doctor.

While ST GLIPTIN 25 is generally well-tolerated, some individuals may experience side effects such as:

• Nausea or diarrhea
• Headache
• Upper respiratory tract infections
• Sore throat
• Joint pain

SEIZMET G1 FORTE Also Available on PCD Pharma Franchise. SEIZMET G1 FORTE combines two essential medications, Glimepiride (1mg) and Metformin (1000mg), for managing type 2 diabetes. This combination aims to enhance blood sugar control and improve patients' overall health.

• Glimepiride: Stimulates the pancreas to release more insulin.
• Metformin: Decreases glucose production in the liver and improves insulin sensitivity.

• Helps control high blood sugar in type 2 diabetes.
• Reduces the risk of diabetes-related complications.
• Supports weight management in diabetic patients.

PCD Pharma SEIZMET G1 FORTE is a prescription medication that combines Glimepiride and Metformin to provide a dual approach to managing type 2 diabetes. It is taken orally, typically once daily with a meal to enhance absorption and reduce gastrointestinal side effects.

• Hypoglycemia (low blood sugar)
• Nausea and vomiting
• Diarrhea
• Stomach pain
• Dizziness

• Regularly monitor blood sugar levels.
• Follow dietary and exercise recommendations.
• Avoid excessive alcohol consumption.
• Inform your doctor of any other medications you are taking.

Metformin Hydrochloride Sustained Release IP 1000 mg Also Available on PCD Pharma Franchise. SEIZMET SR 1000 marketed as SEIZMET SR 1000, is a commonly prescribed medication for managing type 2 diabetes. It helps control blood sugar levels and is typically used in combination with a proper diet and exercise regimen. This formulation offers the benefit of sustained release, ensuring a steady release of the medication over time.

• Metformin works by decreasing the amount of glucose produced by the liver.
• It increases the sensitivity of muscle cells to insulin, promoting better glucose uptake.
• Reduces the absorption of glucose from the intestines.

• Management of type 2 diabetes mellitus.
• Often prescribed when diet and exercise alone are insufficient for blood sugar control.
• Can be used in combination with other antidiabetic medications.

• A sustained-release formulation of SEIZMET SR 1000 PCD Pharma..
• Designed to release the active ingredient slowly over time.
• Helps maintain consistent blood sugar levels throughout the day.

• Gastrointestinal issues such as nausea, vomiting, and diarrhea.
• Risk of lactic acidosis, a rare but serious condition.
• Possible vitamin B12 deficiency with long-term use.

• Regular monitoring of kidney function is recommended.
• Not suitable for patients with severe kidney or liver conditions.
• Should be taken with food to minimize gastrointestinal side effects.

ZENCOBAL SL Also Available on PCD Pharma Franchise. ZENCOBAL SL is an orally disintegrating tablet containing Methylcobalamin (1500mcg), a form of vitamin B12 essential for nerve health and blood cell production. This convenient, fast-acting formulation ensures optimal absorption and efficacy.

Methylcobalamin is a coenzyme form of vitamin B12 that plays a vital role in maintaining nerve function and producing red blood cells. It aids in DNA synthesis, supports brain health, and helps convert homocysteine to methionine, reducing the risk of cardiovascular diseases.

• Neuropathy: Helps manage nerve pain and numbness.
• Anemia: Treats vitamin B12 deficiency-related anemia.
• Cognitive Health: Supports brain function and reduces the risk of cognitive decline.

PCD Pharma ZENCOBAL SL is a fast-dissolving tablet that provides a high dose of Methylcobalamin (1500mcg). It is designed for individuals who need a quick and efficient way to boost their B12 levels, especially those with malabsorption issues.

Side Effects

• Nausea
• Headache
• Dizziness
• Swelling
• Allergic reactions

• Consult a Doctor: Before starting, consult with a healthcare provider, especially if you have any pre-existing conditions.
• Pregnancy and Breastfeeding: Safe for use but should be taken under medical supervision.
• Storage: Keep in a cool, dry place away from direct sunlight.

ST-GLIPTIN M 50/500 Also Available on PCD Pharma Franchise. ST-GLIPTIN M 50/500 is a combination medication containing Sitagliptin (50mg) and Metformin SR (500mg). This oral medication is used to manage blood sugar levels in adults with type 2 diabetes. It helps improve glycemic control along with diet and exercise.

How Does PCD Pharma Products ST-GLIPTIN M 50/500 Work?

• Sitagliptin: Inhibits DPP-4 enzyme, increasing incretin levels to enhance insulin secretion and decrease glucagon release.
• Metformin SR: Reduces hepatic glucose production, improves insulin sensitivity, and delays intestinal glucose absorption.

Uses of ST-GLIPTIN M 50/500

• Primarily used to manage type 2 diabetes mellitus.
• Helps control blood sugar levels in combination with diet and exercise.
• May be used in combination with other antidiabetic medications.

What is ST-GLIPTIN M 50/500?

PCD Pharma ST-GLIPTIN M 50/500 is a fixed-dose combination tablet that combines two antidiabetic agents. Sitagliptin is a DPP-4 inhibitor, while Metformin is a biguanide, both working together to control high blood sugar.

Side Effects

• Common: Nausea, vomiting, diarrhea, headache, and upper respiratory tract infection.
• Serious: Lactic acidosis (rare but serious), pancreatitis, severe hypoglycemia.

Safety Information

• Monitor Kidney Function: Regular monitoring is necessary as Metformin can affect kidney function.
• Alcohol: Avoid excessive alcohol intake.
• Pregnancy & Breastfeeding: Consult your doctor before use.
• Dosage: Follow prescribed dosage; do not adjust without medical advice.
• Regular Monitoring: Regular blood sugar level checks are essential.

TRI-GLICLAGLAZE 40 Also Available on PCD Pharma Franchise. TRI-GLICLAGLAZE 40 is a powerful oral anti-diabetic medication formulated to manage Type 2 Diabetes Mellitus effectively. This combination of three potent drugs—Gliclazide, Pioglitazone, and Metformin—works synergistically to control high blood sugar levels, improve insulin sensitivity, and help patients achieve better glycemic control. TRI-GLICLAGLAZE 40 is designed for patients who struggle to manage blood glucose levels with single medications or lifestyle changes alone. It is a comprehensive solution for long-term diabetes management and reducing the risk of complications related to uncontrolled blood sugar.

• Effective Blood Sugar Control: TRI-GLICLAGLAZE 40 helps maintain optimal blood glucose levels by targeting different aspects of diabetes management, such as stimulating insulin release, improving insulin sensitivity, and reducing glucose production.
• Reduces Insulin Resistance: Pioglitazone and Metformin work together to lower insulin resistance, making it easier for the body to use insulin effectively.
• Improves Long-Term Glycemic Control: By combining three active ingredients, this medication is particularly beneficial for those struggling with glycemic control through diet or monotherapy alone.
• Reduces Risk of Diabetes Complications: Controlling blood sugar levels helps prevent diabetes-related complications such as nerve damage, kidney disease, and cardiovascular problems.
• Supports Weight Management: Metformin, in particular, has been known to assist with weight management, which is important for patients with Type 2 Diabetes.

TRI-GLICLAGLAZE 40 works through a multi-faceted mechanism to lower blood glucose levels:

1. Gliclazide stimulates the beta cells in the pancreas to release more insulin, which lowers blood sugar levels post-meal.

2. Pioglitazone enhances the body's sensitivity to insulin by promoting glucose uptake in the muscle and fat cells while also decreasing glucose production in the liver.

3. Metformin reduces the production of glucose in the liver and improves insulin sensitivity. It also decreases the absorption of sugar from the intestines, ensuring better blood sugar control throughout the day.

This combination of ingredients targets multiple pathways involved in glucose regulation, making it an effective option for individuals with Type 2 Diabetes who require more comprehensive blood sugar control.

• Take  PCD Pharma Products TRI-GLICLAGLAZE 40 exactly as prescribed by your doctor.
• Usually, it is taken once or twice daily with meals to minimize gastrointestinal discomfort.
• Swallow the tablet whole with water—do not crush or chew the tablet.

Diabetes management often requires a multifaceted approach to address the complexities of glucose regulation. Glimiteris Trio 0.5/0.2/500 Also Available on PCD Pharma Franchise.Glimiteris Trio 0.5/0.2/500 offers a synergistic combination of three proven antidiabetic agents. This tablet not only targets fasting and postprandial blood glucose but also improves the body’s insulin utilization, ensuring better glycemic control and reducing the risk of complications associated with diabetes.

• Effective Blood Sugar Management: Works on multiple pathways to control both fasting and postprandial blood glucose levels.
• Reduces Insulin Resistance: Enhances the body's response to insulin, improving its efficacy.
• Minimizes Post-Meal Glucose Spikes: Voglibose slows carbohydrate digestion and absorption, keeping postprandial glucose in check.
• Improves Long-Term Glycemic Control: Helps in achieving and maintaining stable HbA1c levels.
• Sustained Release Formula: Metformin’s SR formulation ensures prolonged action, reducing the need for frequent dosing.
• Comprehensive Diabetes Management: Prevents complications like neuropathy, retinopathy, and cardiovascular issues associated with diabetes.

• Glimepiride: Stimulates the pancreas to release insulin, directly lowering blood glucose levels.
• Voglibose: Inhibits enzymes that break down carbohydrates into glucose, thereby delaying glucose absorption and controlling post-meal spikes.
• Metformin Hydrochloride SR: Decreases hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity, ensuring balanced glucose levels throughout the day.

Together, these three ingredients address the multifaceted nature of type 2 diabetes, providing a holistic solution for effective blood sugar control.

1. Dosage: Take one tablet as prescribed by your healthcare professional, usually once or twice daily with meals.
2. Swallow Whole: Do not crush or chew the tablet; it is designed for sustained release.
3. Timing: Preferably consume with a meal to reduce gastrointestinal discomfort and optimize efficacy.
4. Follow Medical Advice: Stick to the prescribed dosage and schedule for optimal results.

Always consult your doctor before starting or adjusting your dosage.

While PCD Pharma Glimiteris Trio 0.5/0.2/500 is generally well-tolerated, some individuals may experience side effects, including:

• Common Side Effects:

  • Nausea, vomiting, or diarrhea
  • Stomach discomfort or flatulence
  • Mild hypoglycemia (low blood sugar levels)

• Rare but Serious Side Effects:

  • Severe hypoglycemia
  • Lactic acidosis (from Metformin)
  • Allergic reactions such as rash or itching

GLIEMPAFLOZIN MET is an advanced oral medication designed for the effective management of Type 2 Diabetes Mellitus. This combination of Empagliflozin (5mg) and Metformin Hydrochloride (500mg) helps regulate blood sugar levels, improve insulin sensitivity, and reduce the risk of diabetes-related complications. It is commonly prescribed as part of a comprehensive diabetes care plan, including diet and lifestyle modifications.

• Effective Blood Sugar Control – Helps maintain stable blood glucose levels.
• Reduces Insulin Resistance – Enhances the body's ability to utilize insulin efficiently.
• Promotes Weight Management – Empagliflozin aids in weight loss by eliminating excess glucose.
• Improves Cardiovascular Health – Lowers the risk of heart disease in diabetic patients.
• Supports Kidney Function – Helps reduce the progression of diabetic kidney disease.
• Lower Risk of Hypoglycemia – Unlike some other diabetes medications, it has a lower risk of causing dangerously low blood sugar levels.

GLIEMPAFLOZIN MET combines two powerful antidiabetic agents to provide synergistic effects:

• Empagliflozin (SGLT2 Inhibitor): Blocks glucose reabsorption in the kidneys, allowing excess sugar to be excreted through urine. This helps lower blood glucose levels effectively.
• Metformin (Biguanide): Works by decreasing glucose production in the liver and improving insulin sensitivity, leading to better glucose utilization by body tissues.

Together, these mechanisms help in long-term diabetes management, reducing complications and improving overall well-being.

• Take one tablet as prescribed by your healthcare provider.
• Preferably consume with meals to minimize stomach discomfort.
• Swallow the tablet whole with water; do not crush or chew.
• Maintain a healthy diet and exercise routine for optimal results.
• Regular blood sugar monitoring is recommended to track progress.

While GLIEMPAFLOZIN MET is generally well-tolerated, some individuals may experience:

Common Side Effects:

• Nausea, vomiting, or diarrhea
• Increased urination
• Mild dehydration
• Weakness or dizziness

Serious Side Effects (Seek Medical Attention):

• Ketoacidosis: Unusual fatigue, nausea, vomiting, or breathing difficulties.
• Urinary Tract Infections (UTIs): Burning sensation while urinating, fever, or pelvic pain.
• Lactic Acidosis (Rare but Severe): Muscle pain, trouble breathing, irregular heartbeat.

If any severe reactions occur, consult a doctor immediately.

GLIEMPAFLOZIN MET 12.5mg/1000mg is an advanced combination medication formulated for the management of Type 2 Diabetes Mellitus. This dual-action therapy helps improve glycemic control by reducing blood sugar levels through two complementary mechanisms. It is ideal for individuals who require a combination of SGLT2 inhibition and biguanide therapy for effective blood sugar regulation. Along with a proper diet and regular exercise, this medication aids in better diabetes management and reduces the risk of diabetes-related complications.

•  Effective Blood Sugar Control – Helps lower HbA1c levels.
• Weight Management – Empagliflozin aids in weight loss by eliminating excess glucose through urine.
• Cardiovascular Benefits – Reduces the risk of heart disease in diabetic patients.
• Improves Insulin Sensitivity – Enhances the body's response to insulin.
• Supports Kidney Function – Empagliflozin helps protect kidney function by reducing strain on the nephrons.
• Reduces the Risk of Hypoglycemia – Unlike some other diabetes treatments, this combination has a lower risk of causing low blood sugar episodes.

• Empagliflozin works by blocking SGLT2 (Sodium-Glucose Co-Transporter-2) in the kidneys, leading to the excretion of excess glucose through urine.
• Metformin decreases hepatic glucose production, slows glucose absorption from the intestines, and enhances insulin sensitivity in peripheral tissues.
• Together, these mechanisms ensure better glycemic control while reducing the burden on the pancreas and insulin production.

•  Dosage: Take as prescribed by your healthcare provider.
• Timing: Usually taken once or twice daily with meals to reduce gastrointestinal side effects.
• Swallow Whole: Do not crush, chew, or break the tablet.
• Lifestyle Recommendations: Maintain a healthy diet, regular physical activity, and weight management for best results.

While GLIEMPAFLOZIN MET 12.5mg/1000mg is well-tolerated, some individuals may experience mild to moderate side effects, such as:

• Frequent urination (due to Empagliflozin)
• Dehydration and low blood pressure
• Gastrointestinal issues like nausea, diarrhea, or stomach upset
• Yeast infections (especially in women)
• Vitamin B12 deficiency (due to prolonged Metformin use)

Warning: In rare cases, it may cause lactic acidosis or diabetic ketoacidosis. Consult your doctor immediately if you experience severe weakness, dizziness, difficulty breathing, or chest pain.

GLIEMPAFLOZIN MET ER is a combination medication used to manage type 2 diabetes mellitus (T2DM) by helping control blood sugar levels effectively. It contains two powerful anti-diabetic agents, Empagliflozin and Metformin Hydrochloride (Extended Release), which work together to enhance glucose regulation and reduce the risk of diabetes-related complications. This medication is recommended for patients who require additional glycemic control beyond lifestyle changes and monotherapy treatments.

•  Effective Blood Sugar Control – Helps reduce and maintain optimal blood glucose levels in type 2 diabetic patients.
• Weight Management – Empagliflozin promotes caloric loss through urinary glucose excretion, potentially aiding in weight reduction.
• Reduced Risk of Cardiovascular Diseases – Beneficial for heart health, lowering the risk of cardiac complications in diabetic patients.
• Insulin Sensitivity Improvement – Metformin enhances insulin function, reducing insulin resistance.
• Lower Risk of Hypoglycemia – A balanced mechanism of action ensures stable blood glucose levels without sudden drops.
• Kidney Protection – Empagliflozin may help protect against diabetic nephropathy by reducing kidney stress.
• Extended-Release Formula – Ensures long-lasting blood sugar control with a once-daily dosage for improved patient compliance.

• Empagliflozin (SGLT2 Inhibitor) – Blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting its excretion through urine, thereby reducing blood sugar levels.
• Metformin Hydrochloride (Biguanide) – Reduces glucose production in the liver, enhances insulin response, and delays glucose absorption in the digestive tract.
• Together, they provide a dual action approach for better glycemic control while minimizing side effects like hypoglycemia.

• Dosage: Take one tablet per day, preferably with food or as directed by your healthcare provider.
• Swallow whole with a glass of water; do not crush or chew.
•  Maintain a healthy diet and follow a regular exercise routine for optimal results.
• Regular monitoring of blood sugar levels is advised.

Do not stop taking this medication without consulting your doctor.

Some individuals may experience mild to moderate side effects, including:

• Frequent urination (due to glucose excretion)
• Dehydration (increased fluid loss)
• Nausea, vomiting, or stomach upset
• Diarrhea or constipation
• Metallic taste in the mouth
• Low blood pressure (Hypotension)
• Vitamin B12 deficiency (with long-term use of Metformin)
• Urinary tract infections (UTIs) or genital infections

 Seek medical attention if you experience severe allergic reactions, extreme dizziness, or difficulty breathing.

• Benfotiamine is a fat-soluble form of Vitamin B1 that improves absorption and promotes healthy nerve and glucose metabolism.
• Alpha Lipoic Acid is a powerful antioxidant that protects nerves from oxidative damage and increases insulin sensitivity.
• Inositol is necessary for maintaining healthy cell membranes and nerve signal transmission.
• Mecobalamin (Methylcobalamin): An active form of Vitamin B12 that is essential for nerve regeneration and red blood cell formation.
• Folic acid promotes DNA synthesis, cardiovascular health, and nervous system function.
• Chromium improves insulin action and helps control blood sugar levels.
• Selenium is a vital antioxidant that protects cells from oxidative stress and boosts immune function.

• Promotes nerve health by preventing and managing peripheral neuropathy and diabetic nerve damage.
• Enhances Antioxidant Defense: Neutralizes free radicals, lowering oxidative stress, which can harm nerve tissues.
• Improves Energy Metabolism: Promotes the conversion of nutrients into energy, increasing overall vitality.
• Improves Insulin Sensitivity: Helps regulate blood sugar levels, which is beneficial for diabetics.
• Supports Cardiovascular Health: Folic acid and antioxidants work together to improve heart health.
• Strengthens Immunity: Selenium and other nutrients improve immune system function and resilience.

• BENOTIAMINE PLUS CAPSULES function using a synergistic combination of ingredients:
• Benfotiamine targets the advanced glycation end-products (AGEs) that cause nerve damage in diabetes.
• Alpha Lipoic Acid reduces oxidative stress and increases blood flow to the nerves.
• Inositol and mecobalamin promote nerve cell repair and improve nerve signal transmission.
• Chromium enhances glucose metabolism, whereas selenium provides additional cellular protection.
• Together, these components offer comprehensive support for nerve health, metabolic balance, and oxidative protection.

• Dosage: Take one capsule once or twice daily, or as directed by your healthcare provider.
• Method: Swallow with water, preferably after a meal for maximum absorption.
• Important: Consistent daily use is required for best results.

• Mild gastrointestinal discomfort (like nausea or diarrhea)
• Allergic reactions (rash or itching, especially among sensitive individuals)
• Headache or dizziness is extremely rare.
• If you experience any severe or persistent side effects, stop using the product and contact your healthcare provider right away.

• Effective Blood Sugar Control: TRI-GLICLAGLAZE 40 promotes optimal blood glucose levels by addressing various aspects of diabetes management, such as stimulating insulin release, improving insulin sensitivity, and lowering glucose production.Pioglitazone and Metformin work together to reduce insulin resistance, allowing the body to use insulin more effectively.
• Improves Long-Term Glycemic Control: Because it contains three active ingredients, this medication is especially beneficial for those who are having difficulty controlling their blood sugar levels through diet or monotherapy alone.
• Reduces the Risk of Diabetes Complications: Keeping blood sugar under control helps to avoid diabetes-related complications like nerve damage, kidney disease, and cardiovascular problems.

• Gliclazide stimulates the pancreas' beta cells to release more insulin, lowering blood sugar levels after meals.

• Pioglitazone improves insulin sensitivity by increasing glucose uptake in muscle and fat cells while decreasing glucose production in the liver.

• Metformin reduces glucose production in the liver and increases insulin sensitivity. It also reduces sugar absorption from the intestines, resulting in improved blood sugar control throughout the day.

• Take TRIGLICLAGLAZE 40 exactly as directed by your doctor.
• Typically, it is taken once or twice daily with meals to alleviate gastrointestinal discomfort.
• Swallow the tablet whole with water; do not crush or chew it.
• To achieve optimal blood sugar control, continue to follow your diet and exercise plan while taking the medication.
• Do not skip doses, and if you miss one, consult your doctor.

• Hypoglycemia (Low Blood Sugar): Gliclazide's insulin-stimulating properties can cause low blood sugar, especially if meals are skipped or exercise is excessive.

• Metformin is known to cause digestive issues in some people, such as nausea, vomiting, diarrhea, and stomach cramps.

• Weight Gain: Pioglitazone may cause weight gain in some people due to increased fat storage.

• Dapagliflozin (10mg) is an SGLT2 inhibitor that lowers blood glucose by increasing glucose excretion via urine.
• Pioglitazone (15mg) is a thiazolidinedione that improves insulin sensitivity in muscle, fat, and liver tissues, thereby increasing glucose utilization.

• Helps to improve glycemic control in Type 2 Diabetes Mellitus.
• Reduces insulin resistance and improves glucose uptake in peripheral tissues.
• Increases urinary glucose excretion, which aids in blood sugar reduction.
• Dapagliflozin's glucose-lowering effect helps with weight management.
• Provides cardiovascular benefits by lowering the risk of heart failure hospitalization.
• Provides renal protection by lowering albuminuria and slowing kidney disease progression.
• Improves lipid profile and aids in managing metabolic syndrome components.

• Dapagliflozin inhibits SGLT2 in the proximal renal tubules, reducing filtered glucose reabsorption and increasing urinary glucose excretion, which lowers plasma glucose levels.
• Pioglitazone activates PPAR-γ, improving insulin sensitivity in adipose tissue, skeletal muscle, and liver. This leads to improved glucose uptake and reduced hepatic glucose output.Together, they provide complementary benefits for blood sugar management and insulin resistance.

• Take GLIDAPA PIO exactly as directed by your healthcare provider.
• Usually taken once a day, with or without food, and ideally at the same time every day.
• Avoid crushing or chewing the tablet; instead, swallow it whole with a glass of water.
• To achieve the best results, follow your doctor's diet, exercise, and lifestyle recommendations.
• Follow your doctor's advice and monitor your blood glucose levels on a regular basis.
• Do not discontinue or change the dosage without first consulting your physician.

• Common side effects include urinary tract infections, genital infections, increased urination, weight gain (due to pioglitazone), and edema (fluid retention).
• Possible gastrointestinal symptoms include nausea, diarrhea, and stomach discomfort.
• There is a risk of hypoglycemia when combined with insulin or sulfonylureas.
• Rare but serious side effects include heart failure exacerbation, bone fractures, bladder cancer risk (associated with long-term pioglitazone use), and ketoacidosis (though uncommon).
• If you experience symptoms such as shortness of breath, sudden weight gain, or painful urination, contact your doctor immediately. 

• Management of type 2 diabetes in adults
• Helps lower elevated blood glucose levels when diet, exercise, or single-drug therapy are insufficient.
• May lower the risk of diabetic complications like neuropathy, nephropathy, and retinopathy.
• Improves long-term glycemic control in insulin-resistant people.

• Hypoglycemia (low blood glucose levels)
• Nausea and vomiting.
• Diarrhea and stomach discomfort
• Headache
• Dizziness
• Weight gain (from glimepiride)
• Metformin causes a metallic taste.
• Lactic acidosis is a serious but rare side effect of metformin.

• You should not take SEIZMET G0.5 FORTE if you have type 1 diabetes or diabetic ketoacidosis.
• Inform your doctor if you have kidney or liver disorders, heart problems, or an alcohol abuse history.
• Excess alcohol consumption during treatment may increase the risk of lactic acidosis.
• This medication should be taken with meals to reduce the gastrointestinal side effects.
• Pregnant or breastfeeding women should use this product only with medical supervision.
• Elderly patients must be carefully monitored for kidney function and blood sugar levels.

LINALIGLIP 2.5 Also Available on PCD Pharma Franchise. LINALIGLIP 2.5 is a medication containing Linagliptin 2.5 mg, used to manage blood sugar levels in adults with type 2 diabetes. Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps improve blood glucose control. This medication is often prescribed when diet and exercise alone do not provide adequate glycemic control.

• DPP-4 Inhibition: Linagliptin works by inhibiting the enzyme DPP-4, which increases the levels of incretin hormones. These hormones help regulate blood sugar by increasing insulin release and decreasing glucagon levels, particularly after meals.

• Type 2 Diabetes Management: Helps lower blood sugar levels in adults with type 2 diabetes.
• Combination Therapy: Can be used alone or in combination with other antidiabetic medications like metformin, sulfonylureas, or insulin.

LINALIGLIP 2.5 is a prescription medication that contains Linagliptin 2.5 mg. It is used primarily for improving blood sugar control in people with type 2 diabetes, helping them achieve better glycemic management when lifestyle changes are not enough.

• Nasopharyngitis (common cold symptoms).
• Hypoglycemia (when used with other antidiabetic medications).
• Headache.
• Pancreatitis (inflammation of the pancreas).
• Allergic reactions such as rash or hives.

• Consult Your Doctor: Before taking LINALIGLIP 2.5 PCD Pharma, inform your doctor about your medical history, especially any history of pancreatitis, kidney issues, or heart problems.
• Monitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to ensure the medication's effectiveness and adjust dosages if necessary.
• Report Side Effects: Immediately report any severe side effects such as persistent abdominal pain, which could indicate pancreatitis.
• Lifestyle Changes: Continue to follow a healthy diet and exercise regimen as prescribed by your healthcare provider to maximize the benefits of LINALIGLIP 2.5.
• Avoid Excessive Alcohol: Limit alcohol consumption to reduce the risk of developing pancreatitis and other complications.

LINALIGOLD M 2.5/850 Also Available on PCD Pharma Franchise.LINALIGOLD M 2.5/850 is a combination medication that contains Metformin (850mg) and Linagliptin (2.5mg). It is designed to help manage blood sugar levels in individuals with type 2 diabetes. This combination works synergistically to improve glycemic control and offers a comprehensive approach to diabetes management.

• Metformin: Reduces glucose production in the liver and improves insulin sensitivity.
• Linagliptin: Inhibits the enzyme DPP-4, leading to increased insulin release and decreased glucagon levels.

• Effective in managing type 2 diabetes.
• Helps in achieving better glycemic control.
• Can be used as part of a treatment plan that includes diet and exercise.

LINALIGOLD M 2.5/850 PCD Pharma is a combination oral medication that combines two antidiabetic agents, Metformin and Linagliptin, to help control blood sugar levels in adults with type 2 diabetes.

• Common: Nausea, diarrhea, stomach pain.
• Serious: Lactic acidosis (rare), pancreatitis, severe joint pain.
• Allergic reactions: Rash, itching, swelling.

• Not suitable for type 1 diabetes or diabetic ketoacidosis.
• Regular monitoring of blood sugar levels is essential.
• Discuss any other medications or supplements with your healthcare provider to avoid interactions.
• Use with caution in patients with kidney or liver issues.

• Improved Blood Sugar Control: Helps in maintaining steady blood glucose levels.
• Dual Action: Combines the benefits of Metformin and Linagliptin for a more effective treatment.
• Convenience: Single tablet for ease of use.
• Weight Neutral: Generally does not cause significant weight gain.

LINALIGLIP M 5/500 Also Available on PCD Pharma Franchise. LINALIGLIP M 5/500 is a combination medication consisting of Linagliptin 5mg and Metformin Hydrochloride (SR) 500mg. This medication is specifically formulated to help manage type 2 diabetes mellitus by optimizing blood sugar levels and improving overall glycemic control.

How Does PCD Pharma Products LINALIGLIP M 5/500 Work?

Linagliptin:

• Inhibits dipeptidyl peptidase-4 (DPP-4)
• Increases insulin release after meals
• Decreases glucagon secretion

Metformin Hydrochloride (SR):

• Increases insulin sensitivity
• Decreases hepatic glucose production
• Slows intestinal glucose absorption

Uses of LINALIGLIP M 5/500

• Primary: Control blood sugar levels in adults with type 2 diabetes
• Supplementary: Improve glycemic control when diet and exercise alone are insufficient

What is PCD Pharma LINALIGLIP M 5/500?

• A dual-action therapy for type 2 diabetes
• Combines the benefits of DPP-4 inhibition and insulin sensitization
• Helps maintain steady blood sugar levels

Side Effects

• Common: Gastrointestinal issues such as nausea, vomiting, diarrhea
• Less Common: Headache, upper respiratory tract infection
• Serious: Lactic acidosis, pancreatitis, severe hypoglycemia

Safety Information

• Monitoring: Regularly monitor blood sugar levels and kidney function
• Precautions: Not recommended for patients with severe renal impairment or a history of lactic acidosis
• Interactions: Consult with your healthcare provider about all medications and supplements you are taking

RAPIGLINIDE VOG 1.0 Also Available on PCD Pharma Franchise.RAPIGLINIDE VOG 1.0 combines two potent antidiabetic agents, Repaglinide (1mg) and Voglibose (0.3mg), to effectively manage blood sugar levels in patients with type 2 diabetes. This combination therapy helps enhance insulin secretion and slow down carbohydrate absorption, offering a comprehensive approach to blood glucose control.

• Repaglinide: Stimulates the pancreas to release insulin in response to meals, helping to control postprandial blood sugar spikes.
• Voglibose: Inhibits enzymes responsible for breaking down carbohydrates into glucose, delaying glucose absorption and reducing post-meal blood sugar levels.

• Management of type 2 diabetes mellitus
• Reduction of postprandial hyperglycemia
• Prevention of diabetes-related complications

RAPIGLINIDE VOG 1.0 PCD Pharma is an oral antidiabetic medication that combines Repaglinide, a meglitinide analog, and Voglibose, an alpha-glucosidase inhibitor. This dual-action drug is designed to help patients achieve better glycemic control.

• Hypoglycemia (low blood sugar)
• Gastrointestinal discomfort (bloating, diarrhea)
• Dizziness
• Headache
• Skin reactions (rash, itching)

• Dosage: Follow the prescribed dosage. Do not alter the dose without consulting a healthcare provider.
• Precautions:
  • Monitor blood sugar levels regularly.
  • Avoid skipping meals to prevent hypoglycemia.
• Interactions: Inform your doctor about all medications and supplements you are taking to avoid potential interactions.
• Contraindications: Not suitable for patients with type 1 diabetes, diabetic ketoacidosis, or severe renal impairment.

RAPIGLINIDE VOG 0.5 Also Available on PCD Pharma Franchise.RAPIGLINIDE VOG 0.5 is a combination medication designed to manage blood glucose levels in individuals with type 2 diabetes. It combines Repaglinide, a meglitinide analog, and Voglibose, an alpha-glucosidase inhibitor. This formulation aims to improve glycemic control by targeting different mechanisms involved in glucose regulation.

• Repaglinide (0.5mg): Stimulates the pancreas to release insulin, reducing blood sugar levels after meals.
• Voglibose (0.3mg): Slows down carbohydrate absorption in the intestines, preventing post-meal spikes in blood glucose.

• Type 2 Diabetes Management: Helps maintain blood sugar levels within the target range.
• Postprandial Hyperglycemia: Reduces blood sugar spikes after meals, essential for overall glucose control.

RAPIGLINIDE VOG 0.5 PCD Pharma is a dual-action oral antidiabetic medication. By combining Repaglinide and Voglibose, it provides a comprehensive approach to managing postprandial blood glucose levels, making it effective for type 2 diabetes patients.

• Common: Hypoglycemia, gastrointestinal disturbances (diarrhea, nausea), headache.
• Serious: Severe hypoglycemia, allergic reactions, liver function abnormalities.

• Monitoring: Regular blood sugar monitoring is essential to avoid hypoglycemia.
• Diet and Exercise: Follow a balanced diet and exercise regimen as advised by your healthcare provider.
• Interactions: Inform your doctor about all medications and supplements you are taking to avoid potential interactions.
• Pregnancy and Breastfeeding: Consult your doctor before use if you are pregnant, planning to become pregnant, or breastfeeding.

VILDIABATE PIO Also Available on PCD Pharma Franchise. VILDIABATE PIO combines two potent medications, Vildagliptin (50 mg) and Pioglitazone Hydrochloride (15 mg), to help manage type 2 diabetes mellitus. This combination therapy is designed to enhance glycemic control when diet and exercise alone are insufficient.

The combination of Vildagliptin and Pioglitazone PCD Pharma works synergistically to control blood sugar levels:

• Vildagliptin: Inhibits the enzyme DPP-4, increasing incretin levels, which in turn boost insulin release and reduce glucagon levels in the blood.
• Pioglitazone: Improves insulin sensitivity by acting on peroxisome proliferator-activated receptor-gamma (PPAR-γ) in fat cells, muscle cells, and liver, enhancing glucose uptake and utilization.

VILDIABATE PIO is used for:

• Managing type 2 diabetes mellitus.
• Improving glycemic control in adults.
• Complementing diet and exercise efforts in diabetes management.

This medication is a combination oral therapy specifically designed to address the complex needs of type 2 diabetes patients by combining the benefits of two distinct mechanisms of action to optimize blood sugar control.

Common side effects include:

• Upper respiratory tract infections
• Headache
• Edema (swelling)
• Hypoglycemia (especially when combined with other antidiabetics)
• Weight gain
• Muscle pain

When using VILDIABATE PIO, keep in mind:

• Regularly monitor liver function.
• Be cautious if you have a history of heart failure.
• Inform your doctor about all medications you're taking to avoid potential interactions.
• Not recommended for patients with severe heart failure or active bladder cancer.
• Watch for signs of hypoglycemia and manage accordingly.

LINALIGLIP 5 Also Available on PCD Pharma Franchise.LINALIGLIP 5 containing Linagliptin (5mg), is a medication designed to manage blood sugar levels in adults with type 2 diabetes. It is often prescribed when diet and exercise alone do not provide adequate glycemic control. Linagliptin is a member of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.

• Mechanism: Linagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By preventing this breakdown, Linagliptin increases the levels of incretin hormones, which help regulate blood sugar by increasing insulin release and decreasing glucagon levels.
• Insulin Sensitivity: Enhances the body’s natural insulin production in response to meals.

• Primary Use: Management of blood sugar levels in adults with type 2 diabetes.
• Combination Therapy: Can be used alone or in combination with other antidiabetic medications for better control.
• Adjunct Therapy: Often prescribed alongside diet and exercise for comprehensive diabetes management.

LINALIGLIP 5 PCD Pharma is a prescription medication containing Linagliptin (5mg). It is available in tablet form and is typically taken once daily, with or without food.

• Common: Nasopharyngitis (common cold), headache, and cough.
• Serious: Hypersensitivity reactions, pancreatitis, and severe joint pain.

• Consultation: Inform your healthcare provider about any existing medical conditions, allergies, or other medications you are taking.
• Kidney Function: Unlike other medications, Linagliptin does not require dose adjustment in patients with renal impairment.
• Monitoring: Regular monitoring of blood sugar levels is essential.
• Allergies: Be aware of any allergic reactions and seek immediate medical attention if they occur.

TENELIGOLD PM 500 Also Available on PCD Pharma Franchise. TENELIGOLD PM 500 is a combination medication that includes Teneligliptin (20 mg), Pioglitazone (15 mg), and Extended Release Metformin Hydrochloride (500 mg). This medication is designed to provide comprehensive management of type 2 diabetes by combining three potent antidiabetic agents to improve blood sugar control.

How Does  PCD Pharma Products Work?

• Teneligliptin: Inhibits the enzyme DPP-4, leading to increased levels of incretin hormones, which enhance insulin secretion and reduce glucagon release.
• Pioglitazone: Enhances insulin sensitivity in muscle and adipose tissue, leading to better glucose uptake and utilization.
• Metformin ER: Reduces hepatic glucose production and improves insulin sensitivity, providing sustained blood sugar control throughout the day.

Uses of TENELIGOLD PM 500

• Improves Glycemic Control: Helps achieve and maintain target blood glucose levels.
• Reduces HbA1c Levels: Lowers glycated hemoglobin, indicating improved long-term blood sugar management.
• Combination Therapy: Suitable for patients requiring multiple antidiabetic agents for optimal control.

What is TENELIGOLD PM 500?

PCD Pharma TENELIGOLD PM 500 is an oral antidiabetic medication that combines three active ingredients to provide a multifaceted approach to managing type 2 diabetes. It is used when single-agent therapy is inadequate in controlling blood sugar levels.

Side Effects

• Nausea

• Diarrhea

• Upper respiratory tract infections

• Edema (swelling)

• Lactic acidosis

• Hypoglycemia

• Bladder cancer risk (with pioglitazone)

• Heart failure

Safety Information

• Consult Your Doctor: Always seek medical advice before starting or changing dosage.
• Regular Monitoring: Monitor blood sugar levels, liver function, and kidney function regularly.
• Hydration: Ensure adequate fluid intake to prevent dehydration.
• Avoid Alcohol: Limit alcohol consumption as it can increase the risk of lactic acidosis.
• Pregnancy and Breastfeeding: Consult a healthcare provider, as this medication may not be suitable during pregnancy or breastfeeding.

STERIMMUNE DIAB FOOT HEAL Also Available on PCD Pharma Franchise.STERIMMUNE DIAB FOOT HEAL is a specialized cream formulated to provide effective care for diabetic foot complications. This cream combines Salicylic Acid, L-Arginine, Colostrum, Allantoin, and Activated Dimethicone to offer comprehensive healing and protection for diabetic foot issues.

Mechanism of Action:

• Salicylic Acid: Exfoliates dead skin cells, promoting skin renewal and preventing infections.
• L-Arginine: Enhances blood flow, aiding in the healing process.
• Colostrum: Rich in growth factors and antibodies, it supports tissue repair and boosts the immune response.
• Allantoin: Soothes and moisturizes the skin, facilitating faster wound healing.
• Activated Dimethicone: Forms a protective barrier, keeping the skin hydrated and protected from external irritants.

Indications:

• Diabetic foot ulcers
• Dry and cracked feet
• Skin protection and hydration

Composition and Benefits:

• Salicylic Acid: A keratolytic agent that helps remove dead skin cells.
• L-Arginine: An amino acid that improves circulation and promotes healing.
• Colostrum: A natural product with healing and immune-boosting properties.
• Allantoin: Known for its ability to soothe and protect the skin.
• Activated Dimethicone: Provides a moisture barrier to prevent dryness and irritation.

Possible Reactions:

• Mild skin irritation or redness
• Allergic reactions in sensitive individuals

• Increases Insulin Production: Vildagliptin works by inhibiting the enzyme DPP-4, which leads to an increase in insulin secretion in response to meals.
• Decreases Glucagon Release: It reduces the amount of glucose produced by the liver by decreasing the hormone glucagon.
• Improves Blood Sugar Control: By enhancing the body's natural ability to control blood sugar, Vildagliptin helps maintain better glycemic control.

• Type 2 Diabetes Management: Vildagliptin is used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes.
• Combination Therapy: Often prescribed in combination with other diabetes medications like Metformin.

• DPP-4 Inhibitor: It is a dipeptidyl peptidase-4 inhibitor that enhances the levels of incretin hormones.
• Blood Sugar Regulation: Helps in the regulation of blood glucose levels post meals.

• Common Side Effects: Headache, dizziness, and gastrointestinal discomfort.
• Serious Side Effects: Rarely, it may cause severe pancreatitis or allergic reactions.

• Not for Type 1 Diabetes: Vildagliptin is not recommended for patients with type 1 diabetes.
• Liver Function Monitoring: Regular liver function tests are advised during treatment.
• Kidney Function: Dosage adjustments may be necessary for patients with renal impairment.

Metformin and Vildagliptin Combination

• Enhanced Efficacy: Combining Vildagliptin with Metformin, another antidiabetic drug, can provide better blood sugar control.
• Dual Mechanism: While  PCD Pharma Vildagliptin increases insulin production, Metformin decreases glucose production in the liver.

TENELIGOLD M 1000 Also Available on PCD Pharma Franchise. TENELIGOLD M 1000 is a combination medication designed to manage type 2 diabetes. It contains Metformin SR (1000mg) and Teneligliptin (20mg), both of which work together to improve blood sugar control.

• Metformin SR: This extended-release form of metformin helps decrease glucose production in the liver and increases insulin sensitivity, allowing better glucose uptake by the muscles.
• Teneligliptin: This DPP-4 inhibitor enhances the levels of incretin hormones, which increase insulin release and decrease glucagon levels, resulting in lower blood sugar levels.

• Type 2 Diabetes Management: Helps in maintaining optimal blood glucose levels.
• Improved Glycemic Control: Effective in combination with diet and exercise.

PCD Pharma TENELIGOLD M 1000 is a dual-action tablet combining Metformin SR and Teneligliptin, tailored for patients requiring an intensive approach to control their type 2 diabetes.

• Common: Nausea, diarrhea, stomach pain.
• Serious: Lactic acidosis (a rare but serious metabolic condition), pancreatitis, allergic reactions.

• Consultation Required: Always take under the supervision of a healthcare provider.
• Kidney Function: Regular monitoring is essential, as metformin can affect renal function.
• Diet and Lifestyle: Adhere to a diabetic-friendly diet and exercise regimen for optimal results.

Imeglimin Hydrochloride 1000 mg Also Available on PCD Pharma Franchise .Imeglimin Hydrochloride 1000 mg branded as IMEGLIMON 1000, is a novel oral medication for managing type 2 diabetes mellitus. It represents a new class of antidiabetic agents designed to target key dysfunctions in the diabetic state.

Imeglimin works through a unique mechanism:

• Mitochondrial Targeting: Enhances mitochondrial function, improving insulin sensitivity.
• Insulin Secretion: Stimulates pancreatic beta cells to release insulin in response to glucose.
• Glucose Production: Inhibits hepatic glucose production, helping to regulate blood sugar levels.

Imeglimin Hydrochloride 1000 mg is primarily used to:

• Improve glycemic control in adults with type 2 diabetes.
• Reduce fasting and postprandial blood glucose levels.
• Complement lifestyle modifications such as diet and exercise.

Imeglimin Hydrochloride 

Common side effects of Imeglimin Hydrochloride may include:

• Nausea and vomiting
• Diarrhea
• Abdominal pain
• Headache

When taking IMEGLIMON 1000:

• Consult Your Doctor: Before starting, inform your healthcare provider about any other medications you are taking.
• Monitor Blood Sugar Levels: Regularly check your blood glucose levels to ensure effective management.
• Avoid Alcohol: Limit alcohol consumption as it can affect blood sugar control.
• Adherence: Take the medication as prescribed to maintain consistent blood glucose levels.

GLICLAGLAZE TRIO 40/0.3 Also Available on PCD Pharma Franchise. GLICLAGLAZE TRIO 40/0.3 is a prescription medication used for managing type 2 diabetes. It contains a combination of three active ingredients—Gliclazide IP (40 mg), Metformin Hydrochloride IP (500 mg), and Voglibose IP (0.3 mg)—each targeting different pathways to help control blood sugar levels.

• Provides comprehensive blood sugar control for patients with type 2 diabetes.
• Reduces fasting and post-meal glucose levels.
• Lowers the risk of complications associated with high blood sugar, such as cardiovascular issues and neuropathy.

• PCD Pharma Gliclazide enhances insulin secretion from the pancreas.
• Metformin decreases glucose production in the liver and improves insulin sensitivity.
• Voglibose slows the breakdown of carbohydrates in the intestines, minimizing sudden spikes in blood sugar levels after meals.

• Take this medication as directed by your healthcare provider, typically once or twice daily with meals.
• Swallow the tablet whole with water.
• Do not crush or chew the tablet.
• Regularly monitor your blood sugar levels as advised by your doctor.

• Common: Nausea, diarrhea, stomach pain, and low blood sugar (hypoglycemia).
• Less Common: Headaches, dizziness, and mild gastrointestinal discomfort.
• Rare but Severe: Severe hypoglycemia, lactic acidosis (with metformin), or allergic reactions.